All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
1 warning event since 2017; the latest 2017-10-31.
From the record
Immuron Limited's filings since 2017 show 1 warning event: a late-report notice (Form NT 10-K or NT 10-Q, the latest 2017-10-31) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+24.7% a year over 10 filed years; profitable in 0 of 10.
From the record
Immuron Limited's 10 filed years say what it did: revenue went from AUD 1 million in fiscal 2016 to AUD 7 million in fiscal 2025, up 24.7% a year; it rose in 8 of 9 years; the deepest fall was 94% from fiscal 2020 to fiscal 2021; net income was positive in 0 of 10 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 8.7/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Immuron Limited's shareholder treatment is put at 8.7 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the top 13% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -65%: lost 65¢ per shareholder dollar. Leverage 20%: owes 20¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-06-30, Immuron Limited lost about 65 cents for every dollar of shareholders' money, and gross profitability: its products earned about 47 cents per dollar of everything the company owns. Leverage: it owed about 20 cents per dollar of assets, and net share issuance: its share count grew 1.4% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
top 27% of 315 in its family; net margin -71.6%.
From the record
Immuron Limited's standing among 315 graded names in its industry family: revenue of AUD 7 million in fiscal 2025 is not ranked by size, since the family reports in another currency; a net margin of -71.6% ranks in the top 42%; revenue growth of 111.9% a year over the last 3 filed years ranks in the top 13% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 5.0/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Immuron Limited's leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-04-29 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 7 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 371 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
bottom 47% of 273 in its family for room to expand.
From the record
Immuron Limited's room to grow, from the newest filed statements (fiscal 2025): cash of AUD 3 million against no long-term debt tagged leaves 27.9% of its assets as net cash, top 50% of its family; cash from operations less capital spending is -84.2% of revenue (top 49%); a gross margin of 65.4% (bottom 42%); research spending of 49.4% of revenue (bottom 43%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
top 32% of 306 in its family for growth drivers.
From the record
Immuron Limited's growth drivers, from the filed years to fiscal 2025: revenue grew 111.9% a year over the last three filed years against 24.7% over all 10, speeding up (top 6% of its family); the newest year grew 48.7% (top 26%); research spending grew 76.2% a year (top 4%); capital spending grew -69.1% a year (bottom 6%) (its annual reports). Immuron Limited tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 43% of 233 in its family for expectations against reality.
From the record
Immuron Limited's newest year against its own record: revenue of AUD 7 million in fiscal 2025 came in 41.2% below the AUD 12 million its prior three years' pace pointed to (bottom 22% of its family); net income of AUD 5 million against a prior three-year average of AUD 5 million (bottom 35%); a net margin of -71.6% against losses larger than its revenue before (top 28%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made